← All stocks

SNN vs TXG

Smith & Nephew SNATS Inc. Common Stock vs 10x Genomics Inc. Class A Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

SNN
Smith & Nephew SNATS Inc. Common Stock
Healthcare
27.56
11.53B
TXG
10x Genomics Inc. Class A Common Stock
Healthcare
76.60
9.98B
ACCE scores
SNN
TXG
Composite score
Out of 100
50
42
Growth
40
7
Value
75
15
Quality
67
47
Momentum
17
97
Valuation
SNN
TXG
Price
27.56
76.60
Market cap
11.53B
9.98B
Trailing P/E
18.75
0.00
Forward P/E
11.19
1250.00
EV / EBITDA
9.23
148.50
Dividend yield
2.9%
0.0%
Profitability
SNN
TXG
ROE
11.8%
-9.4%
Net margin
10.1%
-12.2%
Debt / equity
0.59
0.01
Free cash flow
852.00M
130.12M
Growth
SNN
TXG
Revenue growth (YoY)
4.6%
-12.7%
Earnings growth (YoY)
5.7%
0.0%
Analyst target
32.89
52.13
See full analysis